Medtronic Plc Stock Price To Earning
| MDTC34 Stock | BRL 245.59 0.40 0.16% |
Medtronic plc fundamentals help investors to digest information that contributes to Medtronic Plc's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic Plc stock.
Medtronic |
Medtronic plc Company Price To Earning Analysis
Medtronic Plc's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Medtronic Plc Price To Earning | 52.06 X |
Most of Medtronic Plc's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Medtronic plc has a Price To Earning of 52 times. This is 101.47% higher than that of the Healthcare sector and 25.49% lower than that of the Medical Devices industry. The price to earning for all Brazil stocks is 81.27% lower than that of the firm.
Medtronic Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic Plc's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic Plc could also be used in its relative valuation, which is a method of valuing Medtronic Plc by comparing valuation metrics of similar companies.Medtronic Plc is regarded third in price to earning category among its peers.
Medtronic Fundamentals
| Return On Equity | 0.0833 | |||
| Return On Asset | 0.0422 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 625.84 B | |||
| Shares Outstanding | 2.66 B | |||
| Price To Earning | 52.06 X | |||
| Price To Book | 2.03 X | |||
| Price To Sales | 18.03 X | |||
| Revenue | 31.69 B | |||
| Gross Profit | 21.71 B | |||
| EBITDA | 8.78 B | |||
| Net Income | 5.04 B | |||
| Cash And Equivalents | 10.6 B | |||
| Cash Per Share | 3.94 X | |||
| Total Debt | 20.32 B | |||
| Debt To Equity | 0.50 % | |||
| Current Ratio | 2.89 X | |||
| Book Value Per Share | 19.50 X | |||
| Cash Flow From Operations | 7.35 B | |||
| Earnings Per Share | 8.13 X | |||
| Price To Earnings To Growth | 3.05 X | |||
| Number Of Employees | 95 K | |||
| Beta | 0.73 | |||
| Market Capitalization | 589.18 B | |||
| Total Asset | 90.98 B | |||
| Z Score | 17.4 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 90.98 B | |||
| Last Dividend Paid | 2.62 |
About Medtronic Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Medtronic Stock refer to our How to Trade Medtronic Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.